Brind.

Roivant Sciences acquired Immunovant and established Vants as a focused subsidiary.

1 report, 1 independent Updated Aug 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Roivant Sciences acquired Immunovant and established Vants as a focused subsidiary.

Who's involved

What this event is mainly about
Roivant Sciences (United States)

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyRoivant Sciences (ROIV) Announces Q1 2025 Business Update Roivant Sciences Ltd (NASDAQ:ROIV) is one of the Best Mid Cap Growth Stocks to Buy According to Hedge Funds. On August 11, Roivant Sciences L